Titan Bio-Tech [TITANBIO] vs Biocon [BIOCON] Detailed Stock Comparison

Titan Bio-Tech Ltd.

BSE
Loading...

Biocon Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech Ltd. wins in 10 metrics, Biocon Ltd. wins in 9 metrics, with 0 ties. Titan Bio-Tech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Titan Bio-Tech Ltd. Biocon Ltd. Better
P/E Ratio (TTM) 74.64 71.84 Biocon Ltd.
Price-to-Book Ratio 12.19 1.68 Biocon Ltd.
Debt-to-Equity Ratio 5.32 50.02 Titan Bio-Tech Ltd.
PEG Ratio -1.22 0.17 Biocon Ltd.
EV/EBITDA 61.34 19.22 Biocon Ltd.
Profit Margin (TTM) 14.13% 3.59% Titan Bio-Tech Ltd.
Operating Margin (TTM) 16.92% 7.63% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) 16.92% 7.63% Titan Bio-Tech Ltd.
Return on Equity 14.04% 3.66% Titan Bio-Tech Ltd.
Return on Assets (TTM) 12.32% 1.72% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $106.79M $17.18B Biocon Ltd.
Dividend Yield 0.42% 0.26% Titan Bio-Tech Ltd.
1-Year Return 419.45% 17.90% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 10.54 3.37 Biocon Ltd.
Enterprise Value $20.35B $643.51B Biocon Ltd.
EV/Revenue Ratio 10.57 3.82 Biocon Ltd.
Gross Profit Margin (TTM) N/A 67.91% N/A
Revenue per Share (TTM) $47 $133 Biocon Ltd.
Earnings per Share (Diluted) $6.58 $4.87 Titan Bio-Tech Ltd.
Beta (Stock Volatility) -0.48 0.25 Titan Bio-Tech Ltd.

Titan Bio-Tech Ltd. vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

TITANBIO
BIOCON

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%
Biocon Ltd.-0.70%1.66%-3.27%10.34%6.50%7.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%
Biocon Ltd.17.90%71.09%5.03%250.57%603.49%1,357.39%

Performance & Financial Health Analysis: Titan Bio-Tech Ltd. vs Biocon Ltd.

MetricTITANBIOBIOCON
Market Information
Market Cap i₹19.90B₹566.52B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i68,8902,496,867
90 Day Avg. Volume i156,6013,790,310
Last Close₹448.30₹416.05
52 Week Range₹74.73 - ₹555.65₹331.00 - ₹440.40
% from 52W High-19.32%-5.53%
All-Time High₹1,460.00 (Feb 18, 2026)₹487.75 (Dec 21, 2020)
% from All-Time High-69.29%-14.70%
Growth Metrics
Quarterly Revenue Growth0.48%0.09%
Quarterly Earnings Growth0.94%4.73%
Financial Health
Profit Margin (TTM) i0.14%0.04%
Operating Margin (TTM) i0.17%0.08%
Return on Equity (TTM) i0.14%0.04%
Debt to Equity (MRQ) i5.3250.02
Cash & Liquidity
Book Value per Share (MRQ)₹40.29₹207.92
Cash per Share (MRQ)₹0.87₹45.84
Operating Cash Flow (TTM) i₹197.75M₹17.78B
Levered Free Cash Flow (TTM) i₹215.32M₹10.13B
Dividends
Last 12-Month Dividend Yield i0.42%0.26%
Last 12-Month Dividend i₹4.00₹1.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech Ltd. vs Biocon Ltd.

MetricTITANBIO (Apr 24, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i74.6471.84
Forward P/E iN/A38.56
PEG Ratio i-1.220.17
Price to Sales (TTM) i10.543.37
Price to Book (MRQ) i12.191.68
Market Capitalization
Market Capitalization i₹19.90B₹566.52B
Enterprise Value i₹20.35B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i10.573.82
Enterprise to EBITDA i61.3419.22
Risk & Other Metrics
Beta i-0.480.25
Book Value per Share (MRQ) i₹40.29₹207.92

Financial Statements Comparison: Titan Bio-Tech Ltd. vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTITANBIO (2025)BIOCON (2025)
Revenue/Sales i1.56B150.52B
Cost of Goods Sold i892.53M51.98B
COGS % of Revenue i57.0%34.5%
Gross Profit i671.98M98.54B
Gross Margin i43.0%65.5%
Research & Development iN/A6.34B
Operating Income (EBIT) i212.57M16.26B
Operating Margin i13.6%10.8%
EBITDA i285.61M33.60B
EBITDA Margin i18.3%22.3%
Pre-Tax Income i243.67M18.87B
Pre-Tax Income % of Revenue i15.6%12.5%
Income Tax i60.96M4.57B
Income Tax % of Revenue i3.9%3.0%
Net Income (Profit) i215.32M14.29B
Profit Margin i13.8%9.5%

Balance Sheet & Liquidity Metrics

MetricTITANBIO (2025)BIOCON (2025)
Cash & Equivalents i51.28M32.27B
Total Current Assets i790.38M162.86B
Total Current Assets % of Revenue i50.5%108.2%
Total Current Liabilities i177.36M143.34B
Total Current Liabilities % of Revenue i11.3%95.2%
Long-Term Debt i4.19M129.45B
Long-Term Debt % of Revenue i0.3%86.0%
Total Shareholders Equity i1.53B277.13B
Retained Earnings i1.36B189.59B
Retained Earnings % of Revenue i87.0%126.0%
Property, Plant & Equipment i571.62M4.32B

Cash Flow Statement Comparison

MetricTITANBIO (2025)BIOCON (2025)
Operating Cash Flow i197.75M17.78B
Operating Cash Flow % of Revenue i12.6%11.8%
Capital Expenditures i-85.26M-21.36B
Free Cash Flow i106.79M17.18B
FCF Margin i6.8%11.4%
Debt Repayment i-2.69M-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIOBIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i41.32M1.62B
Float Shares i13.13M583.07M
% Held by Insiders i68.21%54.07%
% Held by Institutions i0.00%24.88%
% Held by Public i31.79%21.05%

Dividend Analysis & Yield Comparison: Titan Bio-Tech Ltd. vs Biocon Ltd.

MetricTITANBIOBIOCON
Last 12-Month Dividend i₹4.00₹1.00
Last 12-Month Dividend Yield i0.42%0.26%
3-Year Avg Annual Dividend i₹1.93₹1.33
3-Year Avg Dividend Yield i0.34%0.36%
3-Year Total Dividends i₹5.80₹4.00
Ex-Dividend DateSep 19, 2025Jul 04, 2025